Literature DB >> 11407128

A longitudinal study of pain in hospice and pre-hospice patients.

M R Owens1, B Simmons, P S Gibson, D Weeks.   

Abstract

Pain continues to be a very formidable foe in the care of the hospice patient. The incidence among hospice admissions may range from 50 to 80 percent. With such a high initial incidence of pain, the rapidity with which pain can be controlled becomes a very high priority for the hospice effort. The assessment and management of pain in a home-based hospice program presents some unique problems--and opportunities, in that much of this work is done by hospice nurses on site, rather than by the physician, who might remain quite removed from the process. In the study described below, 250 consecutive admissions to either a hospice, or pre-hospice (bridge) program were assessed for pain on admission. Those with pain scores of 5 or greater (on a 1 to 10 scale) were followed daily for 15 days by phone to reassess pain and treatment effects. Of the 250 consecutive patients surveyed, 41 (16 percent) gave pain scores of 5 or greater. Mean pain scores for the 41 patients dropped to < 5 within 24 hours of admission.

Entities:  

Mesh:

Year:  2001        PMID: 11407128     DOI: 10.1177/104990910101800211

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  4 in total

1.  The epidemiology of pain during the last 2 years of life.

Authors:  Alexander K Smith; Irena Stijacic Cenzer; Sara J Knight; Kathleen A Puntillo; Eric Widera; Brie A Williams; W John Boscardin; Kenneth E Covinsky
Journal:  Ann Intern Med       Date:  2010-11-02       Impact factor: 25.391

2.  Restricting symptoms in the last year of life: a prospective cohort study.

Authors:  Sarwat I Chaudhry; Terrence E Murphy; Evelyne Gahbauer; L Scott Sussman; Heather G Allore; Thomas M Gill
Journal:  JAMA Intern Med       Date:  2013-09-09       Impact factor: 21.873

3.  Restricting Symptoms Before and After Admission to Hospice.

Authors:  Shayan Cheraghlou; Evelyne A Gahbauer; Linda Leo-Summers; Hans F Stabenau; Sarwat I Chaudhry; Thomas M Gill
Journal:  Am J Med       Date:  2016-03-08       Impact factor: 4.965

Review 4.  A user's guide to cannabinoid therapies in oncology.

Authors:  V Maida; P J Daeninck
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.